- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.03. | FDA approves higher Wegovy dose via 4th priority voucher | ||
| 19.03. | Lilly's triple agonist retatrutide passes diabetes test | ||
| 19.03. | Precision psychiatry push starts in Europe | ||
| 19.03. | Generic semaglutide in India, and other weight-loss news | ||
| 19.03. | Alfasigma claims early FDA nod for ex-GSK liver drug | ||
| 19.03. | FDA publishes advice on animal testing alternatives | ||
| 18.03. | Basecamp lifts veil on Trillion Gene Atlas genomics push | ||
| 18.03. | J&J gets FDA okay for psoriasis drug icotrokinra | ||
| 18.03. | First MHRA/NICE aligned guidance due in June | ||
| 18.03. | Hope rises for vaccine against hookworm parasite | ||
| 18.03. | US court says pharma giants must face False Claims suit | ||
| 17.03. | Meningitis outbreak in UK prompts call to widen vaccination | ||
| 17.03. | Alto raises $120m for resistant depression programme | ||
| 17.03. | BioMarin halts Voxzogo trials due to safety signal | ||
| 17.03. | Roche accelerates AI adoption with NVIDIA deal | ||
| 17.03. | US judge rules Kennedy's vaccine changes 'unlawful' | ||
| 16.03. | AZ piles pressure on MSD et al in gastric cancer | ||
| 16.03. | Denying prostate cancer screening 'no longer rational' | ||
| 16.03. | Data builds behind Bayer's Kerendia in kidney disease | ||
| 16.03. | J&J says Inlexzo follow-up 'promising' in bladder cancer | ||
| 16.03. | GSK's RSV shot cleared in US for all adults | ||
| 13.03. | Regenxbio, Solid report data with Duchenne gene therapies | ||
| 13.03. | NHS hospitals 'should resist Palantir software rollout' | ||
| 13.03. | Immutep investors spooked by LAG-3 failure in lung cancer | ||
| 13.03. | Poll finds Americans cutting back elsewhere to fund health |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.